Treg Brown, MD
Orthopaedic Surgery · Herrin, ILNPI 1598870115
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $6,546,960 of the $6,550,704 with a category attached, or 99.9%. Smith+Nephew accounts for 99.9% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $1,485,231, 2.1 times the $695,910 reported in 2019. Among orthopaedic surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $83,983 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$6.5M
- Medical Device Business Services, Inc.$2K
- KCI USA, Inc.$452
- Johnson & Johnson$233
- Pacira Pharmaceuticals Incorporated$110
- Ferring Pharmaceuticals Inc.$95
- plus $456 from 15 others
What the payments were for
- Royalty or licence$6,546,960100%
- Consulting fees$2,7650%
- Food & beverage$9790%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 30 | $6,547,018 |
| Medical Device Business Services, Inc. | 1 | $2,340 |
| KCI USA, Inc. | 2 | $452 |
| Johnson & Johnson | 10 | $233 |
| Pacira Pharmaceuticals Incorporated | 1 | $110 |
| Ferring Pharmaceuticals Inc. | 7 | $95 |
| Stryker | 2 | $56 |
| Pacira Therapeutics, Inc. | 4 | $53 |
| Vertex | 2 | $53 |
| Elite Orthopedics, LLC | 2 | $41 |
| Fidia Pharma USA Inc. | 4 | $33 |
| Amgen | 2 | $31 |
| AbbVie(2 entities) | 2 | $30 |
| Pfizer | 1 | $28 |
| Endo Pharmaceuticals Inc. | 2 | $28 |
| Si-bone, Inc. | 1 | $25 |
| Heraeus Medical, LLC. | 1 | $20 |
| ERMI LLC | 1 | $19 |
| Vericel Corporation | 1 | $13 |
| Bioventus LLC | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Q-FIX$5,495,868
- Q-FIX Hip$1,578,105
- DELTA$2,340
- PREVENA RESTOR ROTO-FORM$425
- EXPAREL$110
How this compares
$6,550,704 in reported general payments places this provider in the 95th percentile of 844 orthopaedic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Herrin
- Robert GolzHerrin$252K
- Steven YoungHerrin$251K
- Peter BonuttiEffingham$24.3M
- Steven HaddadGlenview$12.6M
- Aaron RosenbergChicago$12.4M
- Wayne GoldsteinMorton Grove$4.9M
- Steven ChudikWestmont$4.1M
- Matthew SquireAurora$2.9M
- David ManningBurr Ridge$2.3M
- Ritesh ShahMorton Grove$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.